The PPI network analysis of three databases identified the following subsets of DEGs, including CDC20, CDKN2A, CTSV, FOXM1, KRT23, MAGEA6, and S100A9, which were significantly upregulated in bladder cancer. The gene discussed is CDKN2A; the disease is urinary bladder cancer.